Jpmorgan Chase & CO Avid Bioservices, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 142,191 shares of CDMO stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142,191
Previous 108,684 30.83%
Holding current value
$1.78 Million
Previous $1.24 Million 42.07%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$9.96 - $12.36 $333,729 - $414,146
33,507 Added 30.83%
142,191 $1.76 Million
Q3 2024

Dec 26, 2024
BUY
$6.7 - $12.45 $538,063 - $999,834
80,308 Added 283.01%
108,684 $1.24 Million
Q3 2024

Nov 08, 2024
BUY
$6.7 - $12.45 $538,063 - $999,834
80,308 Added 283.01%
108,684 $1.24 Million
Q2 2024

Dec 26, 2024
SELL
$6.34 - $9.28 $509,152 - $745,258
-80,308 Reduced 73.89%
28,376 $202,000
Q2 2024

Aug 12, 2024
BUY
$6.34 - $9.28 $15,044 - $22,021
2,373 Added 9.13%
28,376 $202,000
Q1 2024

Dec 26, 2024
SELL
$5.86 - $8.79 $484,510 - $726,765
-82,681 Reduced 76.07%
26,003 $174,000
Q1 2024

May 10, 2024
SELL
$5.86 - $8.79 $364,433 - $546,650
-62,190 Reduced 70.52%
26,003 $174,000
Q4 2023

Dec 26, 2024
SELL
$4.64 - $9.56 $95,078 - $195,893
-20,491 Reduced 18.85%
88,193 $573,000
Q4 2023

Feb 12, 2024
BUY
$4.64 - $9.56 $48,896 - $100,743
10,538 Added 13.57%
88,193 $573,000
Q3 2023

Nov 14, 2023
SELL
$9.4 - $14.04 $92,749 - $138,532
-9,867 Reduced 11.27%
77,655 $733,000
Q2 2023

Aug 11, 2023
BUY
$12.96 - $20.93 $121,370 - $196,009
9,365 Added 11.98%
87,522 $1.22 Million
Q1 2023

May 18, 2023
BUY
$13.48 - $18.79 $1.04 Million - $1.45 Million
77,305 Added 9073.36%
78,157 $1.47 Million
Q1 2023

May 11, 2023
SELL
$13.48 - $18.79 $933,355 - $1.3 Million
-69,240 Reduced 98.78%
852 $15,000
Q4 2022

Feb 13, 2023
BUY
$12.61 - $18.74 $165,934 - $246,599
13,159 Added 23.11%
70,092 $965,000
Q3 2022

Nov 14, 2022
BUY
$15.33 - $20.36 $10,071 - $13,376
657 Added 1.17%
56,933 $1.09 Million
Q2 2022

Aug 11, 2022
BUY
$11.63 - $21.55 $119,695 - $221,792
10,292 Added 22.38%
56,276 $858,000
Q1 2022

May 11, 2022
BUY
$16.63 - $27.73 $112,551 - $187,676
6,768 Added 17.26%
45,984 $936,000
Q4 2021

Feb 10, 2022
SELL
$20.7 - $34.18 $1.8 Million - $2.97 Million
-86,794 Reduced 68.88%
39,216 $1.14 Million
Q3 2021

Nov 12, 2021
BUY
$19.05 - $28.32 $2.4 Million - $3.57 Million
126,010 New
126,010 $2.72 Million

Others Institutions Holding CDMO

# of Institutions
209
Shares Held
67.1M
Call Options Held
216K
Put Options Held
4.6K
View Full List

About Avid Bioservices, Inc.

CDMO Quotes by TradingView
  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email